Drug Channels News Roundup, Mid-May 2026: Flawed Launch Price Math, Rising Pharmacy Closures, Hospital Pay Realities, 340B Hospitals vs. Grantees, and a Luxury Take on Specialty Pharmacy

By Bryce Platt, PharmD The onslaught of pharmacy-related news doesn’t end. It may even be increasing in volume due to AI. But don’t worry—I’ve gathered some high-impact information over the last month from my LinkedIn posts that you can quickly read between your sets at the gym. I recommend reading BETWEEN your sets, but some may be brave enough to read during the set itself. In this issue: Why Drug Launch Price Analyses May Be Misleading Pharmacy Closures Are Accelerating—New Data Reveal Where and Why How Hospitals Really Get Paid for Uncompensated Care (It’s More Complicated Than You Think) 340B…

By Bryce Platt, PharmD

The onslaught of pharmacy-related news doesn’t end. It may even be increasing in volume due to AI.

But don’t worry—I’ve gathered some high-impact information over the last month from my LinkedIn posts that you can quickly read between your sets at the gym.

I recommend reading BETWEEN your sets, but some may be brave enough to read during the set itself.

In this issue:

Why Drug Launch Price Analyses May Be Misleading

Pharmacy Closures Are Accelerating—New Data Reveal Where and Why

How Hospitals Really Get Paid for Uncompensated Care (It’s More Complicated Than You Think)

340B Hospitals vs. Federal Grantees: The Overlooked Differences That Matter

Extra: What If Specialty Pharmacy Worked Like a Luxury Hotel? A Surprising Reimagining

P.S. Join my more than 33,000 LinkedIn followers for valuable daily posts at 9 a.m. ET.

340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders.

Don't miss DCI’s upcoming webinar on Friday, June 12, 2026, from 12:00 p.m. to 1:30 p.m. ET. Adam J. Fein and tyler Novotny will unpack the good, the bad, and the ugly of the 340B program—and what it means for you. Click here to learn more and sign up.